Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A Phase 2 Study of Olaparib and Cediranib for the Treatment of Recurrent Ovarian CancerCIRB: Adult CIRB - Early Phase EmphasisLead Group: ETCTNStatus: ActiveReview Status: Available to Open